Marjolein Sluijter

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines

Nadine van Montfoort, Linda Borst, Michael Korrer et al. · Cell · 2018 · 327 citations · Full text

Life Sciences, Immunology, Oncology +12

Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody

Marieke F. Fransen, Marjolein Sluijter, Hans Morreau et al. · Clinical Cancer Research · 2011 · 154 citations

Medicine, Immunology, Oncology +17

Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy

Marit J van Elsas, Jim Middelburg, Camilla Labrie et al. · Cancer Cell · 2024 · 140 citations · Full text

Life Sciences, Immunology, Oncology +16

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

Sumit Kumar, Mark J.A. Schoonderwoerd, Jessie S. Kroonen et al. · Gut · 2022 · 127 citations · Full text

Medicine, Oncology, Pharmacology +16

Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2

Margit H. Lampen, Marjolein Sluijter, Annemieke Geluk et al. · Molecular Immunology · 2012 · 108 citations

Life Sciences, Immunology, Molecular Biology +15